摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1'-羟基黄樟素 | 5208-87-7

中文名称
1'-羟基黄樟素
中文别名
——
英文名称
1'-hydroxysafrole
英文别名
1-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-ol;1-((3,4-methylenedioxy)-phenyl)-2-propenol;1-(1,3-benzodioxol-5-yl)prop-2-en-1-ol
1'-羟基黄樟素化学式
CAS
5208-87-7
化学式
C10H10O3
mdl
——
分子量
178.188
InChiKey
VVBJNJFYBCLUAH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    270.41°C (rough estimate)
  • 密度:
    1.1601 (rough estimate)
  • 溶解度:
    可溶于氯仿(少许)、二氯甲烷(少许)
  • LogP:
    1.796 (est)
  • 蒸汽压力:
    7.78X10-5 mm Hg at 25 °C (est)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

ADMET

代谢
1'-羟基黄樟素通过口服或腹腔注射给雄性大鼠时,大约40%以原形排出;这不受苯巴比妥3-甲基胆蒽给药的影响。胆汁中没有排出1'-羟基黄樟素
When 1'-hydroxysafrole was given orally or by ip injection to male rats, about 40% was excreted unchanged; this was not affected by phenobarbital or 3-methylcholanthrene admin. No 1'-hydroxysafrole was excreted in the bile.
来源:Hazardous Substances Data Bank (HSDB)
代谢
1'-羟基黄樟素尿液中的代谢物包括3'-羟基异黄樟素、3,4-亚甲二氧基苯基乙烯酮二甲氨基哌啶基曼尼希碱以及3,4-亚甲二氧基马尿酸
The urinary metabolites of 1'-hydroxysafrole included 3'-hydroxyisosafrole, 3,4-methylenedioxyphenyl vinyl ketone, the dimethylamino & piperidyl mannich bases, & 3,4-methylenedioxyhippuric acid ...
来源:Hazardous Substances Data Bank (HSDB)
代谢
在人和大鼠中,口服小剂量的黄樟素被迅速吸收,并在24小时内几乎全部通过尿液排出。黄樟素的近致癌物1'-羟基黄樟素3'-羟基异黄樟素在大鼠尿液中以结合物的形式被检测到;然而,在人体中无法证明它们的存在。
In men & rats, small oral doses of safrole were absorbed rapidly & then excreted almost entirely within 24 hr in the urine. 1'-hydroxysafrole, a proximate carcinogen of safrole, & 3'-hydroxyisosafrole were detected as conjugates in the urine of the rat; however, it was not possible to demonstrate their presence in man.
来源:Hazardous Substances Data Bank (HSDB)
代谢
在给动物注射1'-羟基黄樟素的中性尿液提取中,存在未代谢的1'-羟基黄樟素3'-羟基异黄樟素、3,4-亚甲二氧基苯乙烯基酮以及2种未识别的代谢物(分子量为180和226)。在碱性尿液提取中,检测到了二甲氨基哌啶基曼尼希碱代谢物;发现的唯一酸性代谢物是3,4-亚甲二氧基苯乙酰甘氨酸
In the neutral extraction of urine from animals injected with 1'-hydroxysafrole, unmetabolized 1'-hydroxysafrole, 3'-hydroxyisosafrole, 3,4-methylenedioxyphenyl vinyl ketone & 2 unidentified metabolites (mol wt 180 & 226) were present. In the basic urine extraction, the dimethylamino & piperidyl mannich base metabolites were detected; the only acidic metabolite found was 3,4-methylenedioxyhippuric acid.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 副作用
职业性肝毒素 - 第二性肝毒素:在职业环境中的毒性效应潜力是基于人类摄入或动物实验的中毒案例。
Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
毒理性
  • 解毒与急救
/SRP:/ 基本治疗:建立专利气道(如有需要,使用口咽或鼻咽气道)。如有必要,进行吸痰。观察呼吸不足的迹象,如有必要,进行辅助通气。通过非重复呼吸面罩以10至15升/分钟的速度给予氧气。监测肺肿,并在必要时进行治疗……。监测休克,并在必要时进行治疗……。预期癫痫发作,并在必要时进行治疗……。对于眼睛污染,立即用冲洗眼睛。在转运过程中,用0.9%的生理盐(NS)连续冲洗每只眼睛……。给予活性炭……。不要使用催吐剂。在去污染后,用干燥、无菌敷料覆盖皮肤烧伤……。保持体温。/酚类及其相关化合物/
/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Administer activated charcoal ... . Do not use emetics. Cover skin burns with dry, sterile dressings after decontamination ... . Maintain body temperature. /Phenols and related compounds/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 解毒与急救
/SRP:/ 高级治疗:对于无意识、严重肺肿或严重呼吸困难的病人,考虑进行口咽或鼻咽气管插管以控制气道。使用气囊面罩装置的正压通气技术可能有益。考虑使用药物治疗肺肿……。监测心率和必要时治疗心律失常……。开始静脉输注D5W /SRP: "保持开放",最低流量/。如果出现低血容量迹象,使用0.9%生理盐(NS)或乳酸林格液(LR)。对于伴有低血容量迹象的低血压,谨慎给予液体。如果病人在正常血容量时出现低血压,考虑使用血管加压药。注意液体过载的迹象……。如果病人在严重低氧血症、发绀和心脏受损(对氧疗无反应)的情况下出现症状,给予1%亚甲蓝溶液……。使用地西泮劳拉西泮治疗癫痫……。使用丙美卡因化物协助眼部冲洗……。/酚类及相关化合物/
/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Monitor cardiac rhythm and treat arrhythmias if necessary ... . Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Consider vasopressors if patient is hypotensive with a normal fluid volume. Watch for signs of fluid overload ... . Administer 1% solution methylene blue if patient is symptomatic with severe hypoxia, cyanosis, and cardiac compromise not responding to oxygen. ... Treat seizures with diazepam or lorazepam. ... Use proparacaine hydrochloride to assist eye irrigation ... . /Phenols and related compounds/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 人类毒性摘录
/遗传毒性/ 1'-羟基黄樟素...在培养的人类成纤维细胞中诱导了非计划性的DNA修复合成。
/GENOTOXICITY/ 1'-hydroxysafrole ... induced unscheduled DNA repair synthesis in cultured human fibroblasts.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 非人类毒性摘录
实验室动物:慢性暴露或致癌性/ 1'-羟基黄樟素...在雄性幼鼠中比等摩尔浓度的黄樟素产生更高的肝脏肿瘤发生率;在生命的第1、7、14和21天各给予4次皮下注射。在给雄性大鼠喂食含有5500毫克/千克体重的1'-羟基黄樟素8.5-10个月的饮食中,12或16个月处死的大鼠肝脏肿瘤发生率高于接受黄樟素的大鼠;此外,1'-羟基黄樟素还引起了前胃乳头状瘤。当18只成年大鼠每周两次皮下注射18.6微摩尔1'-羟基黄樟素或1'-乙酰氧基黄樟素10周后,观察17-18个月,两组均出现局部肿瘤。在喂食1'-羟基黄樟素的小鼠中观察到肩胛间高发生率(20/65)的肉瘤(主要是血管肉瘤)...。
/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ 1'-hydroxysafrole ... produced a greater incidence of liver tumors in male infant mice than did equimolar concn of safrole; 4 sc injections were given on days 1, 7, 14 & 21 of life. In male rats given 5500 mg 1'-hydroxysafrole/kg of diet for 8.5-10 mo, incidence of liver tumors in rats killed at 12 or 16 mo was higher than that in rats receiving safrole; in addn, forestomach papillomas were produced by 1'-hydroxysafrole. when groups of 18 adult rats ... given twice weekly sc injections of 18.6 umol 1'-hydroxysafrole or 1'-acetoxysafrole for 10 wk, followed by observation for 17-18 mo, local tumors occurred in both groups. A high incidence (20/65) of interscapular sarcomas (mainly angiosarcomas)...observed in mice fed 1'-hydroxysafrole.
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 海关编码:
    2932999099
  • 储存条件:
    通风、低温、干燥

SDS

SDS:7a99250e365db8aa1dd1a0f7f9f0d36b
查看

制备方法与用途

类别:有毒物品

可燃性危险特性:

  • 可燃
  • 燃烧时会产生刺激性烟雾

储运特性:

  • 通风、低温、干燥

灭火剂:

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    1'-羟基黄樟素4-二甲氨基吡啶 、 bis(cyclopentadienyl)titanium (III) chloride 、 三乙胺间氯过氧苯甲酸 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 6.0h, 生成 3'-羟基异黄樟素
    参考文献:
    名称:
    Chakraborty; Mandal; Roy, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2015, vol. 54B, # 7, p. 893 - 901
    摘要:
    DOI:
  • 作为产物:
    描述:
    黄樟素 在 cytochrome P450 2A6 variant 、 甘油 作用下, 以 aq. phosphate buffer 、 甘油 为溶剂, 反应 0.5h, 生成 1'-羟基黄樟素
    参考文献:
    名称:
    通过细胞色素P450 2A6变体代谢7-乙氧基香豆素,黄樟脑,黄烷酮和羟基黄烷酮。
    摘要:
    CYP 2A6是一种人类酶,可代谢许多异生素,包括香豆素,吲哚,尼古丁和致癌的亚硝胺。CYP2A6的基因是多态的。几乎没有数据可以阐明P450基因变异与食品中物质代谢之间的关系。CYP 2A6野生型蛋白和13个突变体(CYP2A6.1,CYP2A6.2,CYP2A6.5,CYP2A6.6,CYP2A6.7,CYP2A6.8,CYP2A6.11,CYP2A6.15,CYP2A6.16,CYP2A6.17 (CYP2A6.18,CYP2A6.21,CYP2A6.23和CYP2A6.25)与NADPH-细胞色素P450还原酶在大肠杆菌中共表达。检查了对7-乙氧基香豆素,香豆素,黄樟脑,黄烷酮和羟基黄酮的羟化酶活性。除CYP2A6.2,CYP2A6.5和CYP2A6以外的十种CYP2A6变体。图6显示了在还原的CO差光谱中典型的P450的Soret峰(450 nm),并具有7-乙氧基香豆素O-脱乙基酶活性。CYP2A6
    DOI:
    10.1002/bdd.1825
点击查看最新优质反应信息

文献信息

  • Synthesis of multiply 13C-labeled furofuran lignans using 13C-labeled cinnamyl alcohols as building blocks
    作者:Kati Haajanen、Nigel P. Botting
    DOI:10.1016/j.steroids.2005.10.005
    日期:2006.3
    Plant lignans are currently being widely studied for their potential benefits for human health as their consumption has been correlated with lower risks for developing chronic diseases, such as breast cancer and coronary heart disease. However, studies of some classes of lignans, in particular the furofurans, are hampered by the lack of suitable standards to allow accurate analysis. Herein, we report
    植物木素目前正因其对人类健康的潜在益处而被广泛研究,因为它们的消费与患乳腺癌和冠心病等慢性病的风险较低有关。然而,由于缺乏合适的标准来进行准确分析,对某些种类的木脂素,特别是呋喃类的研究受到阻碍。在此,我们报告了两种外消旋 (13)C 标记的呋喃木脂素 [7,8,9-(13)C(3)]medioresinol 和 [7,8,9-(13)C(3)] 芝麻素的合成作为 LC-MS 分析的内标。标记的呋喃木脂素是由三重标记的肉桂醇构建的,使用自由基环化方法。
  • Copper(I)-Catalyzed Stereo- and Chemoselective Borylative Radical Cyclization of Alkyl Halides Bearing an Alkene Moiety
    作者:Hiroaki Iwamoto、Sota Akiyama、Keiichi Hayama、Hajime Ito
    DOI:10.1021/acs.orglett.7b00940
    日期:2017.5.19
    The stereoselective borylative radical cyclization of alkyl halides containing an alkene moiety was developed using a copper(I)/diboron catalyst system. The optimized reaction conditions allowed us to control the chemoselectivity between the allylic substitution and the borylative radical cyclization. The borylation products were subsequently converted to highly functionalized organic compounds by
    使用(I)/二催化剂体系开发了含烯烃部分的卤代烷的立体选择性硼烷基自由基环化反应。优化的反应条件使我们能够控制烯丙基取代和基自由基环化之间的化学选择性。随后,通过新形成的C–B键的衍生化,硼酸酯化产物转化为高度官能化的有机化合物。这种基自由基环化为各种杂环化合物的立体选择性合成提供了一种新颖的方法。
  • Asymmetric Synthesis of γ-Secondary Amino Alcohols via a Borrowing-Hydrogen Cascade
    作者:Yupeng Pan、Yipeng You、Dongxu He、Fumin Chen、Xiaoyong Chang、Ming Yu Jin、Xiangyou Xing
    DOI:10.1021/acs.orglett.0c02614
    日期:2020.9.18
    The borrowing-hydrogen (or hydrogen autotransfer) process, where the catalyst dehydrogenates a substrate and formally transfers the H atom to an unsaturated intermediate, is an atom-efficient and environmentally benign transformation. Described here is an example of an asymmetric borrowing-hydrogen cascade for the formal anti-Markovnikov hydroamination of allyl alcohols to synthesize optically enriched
    借贷氢(或氢自动转移)工艺是一种对原子有效的,对环境无害的转化工艺,其中催化剂将底物脱氢并将H原子正式转移至不饱和中间体。这里描述的是不对称的借位氢级联的实例,用于烯丙醇的形式上的反马尔科夫尼科夫加氢胺化反应,以合成光学富集的γ-仲基醇。通过利用具有最小立体异构性的Ru- (S)-i PrPyme催化剂,开发了一种包括脱氢,共轭加成和不对称还原的级联过程。温和的条件,官能团的耐受性和广泛的底物范围(54个实例)证明了催化体系的合成实用性。
  • Iridium-Catalyzed Enantioselective Allylic Substitution with Aqueous Solutions of Nucleophiles
    作者:Tobias Sandmeier、F. Wieland Goetzke、Simon Krautwald、Erick M. Carreira
    DOI:10.1021/jacs.9b05830
    日期:2019.8.7
    The iridium-catalyzed asymmetric allylic substitution under biphasic conditions is reported. This approach allows the use of various unstable and/or volatile nucleophiles including hydrazines, methyl-amine, t-butyl hydroperoxide, N-hydroxylamine, α-chloroacetaldehyde and glutaraldehyde. This transformation pro-vides rapid access to a broad range of products from simple starting materials in good yields
    报道了双相条件下催化的不对称烯丙基取代。这种方法允许使用各种不稳定和/或挥发性亲核试剂,包括甲胺叔丁基过氧化氢、N-羟胺、α-氯乙醛戊二醛。这种转变提供了从简单的起始材料以良好的产率和高达 > 99% ee 和 20:1 dr 快速获得广泛产品的途径。此外,这些产品可以有效地加工成多种环状和非环状化合物,最多可带有四个立体中心。
  • 1,3-Dioxa-[3,3]-sigmatropic Oxo-Rearrangement of Substituted Allylic Carbamates: Scope and Mechanistic Studies
    作者:Maddalen Agirre、Sylvain Henrion、Ivan Rivilla、José I. Miranda、Fernando P. Cossío、Bertrand Carboni、José M. Villalgordo、François Carreaux
    DOI:10.1021/acs.joc.8b01320
    日期:2018.12.21
    alkenyl-substituted allylic alcohols with activated isocyanates is reported. The reorganization of bonds is highly dependent on the electron density of the aromatic ring and the nature of isocyanate used. This metal-free tandem reaction from branched allyl alcohols initiated by a carbamoylation reaction and followed by a sigmatropic rearrangement thus offers a new access to (E)-cinnamyl and conjugated (E,E)-diene
    据报道,在用活化的异氰酸酯处理芳基和烯基取代的烯丙基醇的过程中,发生了意外的1,3-二氧杂-[3,3]-σ重排。键的重组高度取决于芳环的电子密度和所用异氰酸酯的性质。由氨基甲酸酯化反应引发的支链烯丙醇的无属串联反应,然后发生σ重排,因此提供了新的途径获得(E)-肉桂基和共轭(E,E)-二烯氨基甲酸酯,例如N-酰基和N -磺酰基衍生物。为了使这种现象合理化,进行了计算研究,并且进行了重排进行动力学分析。
查看更多

同类化合物

(5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) 黄樟素氧化物 黄樟素乙二醇; 2',3'-二氢-2',3'-二羟基黄樟素 黄樟素 风藤酰胺 风藤酮 非哌西特盐酸盐 非哌西特 盐酸盐 角秋水仙碱 螺[1,3-苯并二氧戊环-2,1'-环己烷]-5-胺 蓝细菌 苯并[d][1,3]二氧杂环戊烯-5-胺盐酸盐 苯并[d][1,3]二氧代l-5-甲基(2-氧代乙基)氨基甲酸叔丁酯 苯并[d][1,3]二氧代l-5-氨基甲酸叔丁酯 苯并[d][1,3]二氧代-4-甲腈 苯并[d][1,3]二氧代-4-氨基甲酸叔丁酯 苯并[d[1,3]二氧代-4-羧酰胺 苯并[1,3]二氧杂环戊烯-5-基甲基2-氯乙酸酯 苯并[1,3]二氧杂环戊烯-5-基甲基-苄基-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-[2-(4-氟-苯基)-乙基]-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(四氢-呋喃-2-基甲基)-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(2-氟-苄基)-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(1-甲基-哌啶-4-基)-胺 苯并[1,3]二氧代l-5-甲基-吡啶-3-甲基-胺 苯并[1,3]二氧代l-5-甲基-(4-氟-苄基)-胺 苯并[1,3]二氧代l-5-乙酸甲酯 苯并[1,3]二氧代-5-羧酰胺盐酸盐 苯并[1,3]二氧代-5-甲基肼盐酸盐 苯并[1,3]二氧代-5-甲基吡啶-4-甲胺 苯并[1,3]二氧代-5-甲基-吡啶-2-甲胺 苯并[1,3]二氧代-5-乙酰氯 苯并-1,3-二氧杂环戊烯-5-甲醇丙酸酯 苯乙酸,1-(1,3-苯并二氧杂环戊烯-5-基)-3-丁烯-1-基酯 苯乙酮O-((4-(3,4-亚甲二氧基苄基)-1-哌嗪-1-基)羰基甲基)肟 苯,1-甲氧基-6-硝基-3,4-亚甲二氧基- 芝麻酚 芝麻林素 脲,N-1,3-苯并二噁唑-5-基-N'-(2-溴乙基)- 胡椒醛肟 胡椒醛-((Z)-O-苯基氨基甲酰基肟) 胡椒醛,二苄基缩硫醛 胡椒醛 胡椒醇 胡椒酸酰氯 胡椒酸 胡椒腈 胡椒环乙酮肟 胡椒环 胡椒基重氮酮 胡椒基甲醛